Aspect Biosystems is a biotechnology company developing bioprinted tissue therapeutics to transform how we treat disease. By combining its proprietary microfluidic 3D bioprinting technology, therapeutic cells, and materials science, Aspect is creating a pipeline of allogeneic cell-based tissue therapeutics to replace or repair damaged organ functions. The company is also partnering with leading researchers and industry innovators worldwide to tackle the biggest challenges in regenerative medicine.
Chemix offers high-performance batteries custom-designed for specific EV market segments including e-motorcycles, sports cars, long-range premium EVs, and more. Chemix achieves this through a purpose-built AI-based battery design platform, MIX, coupled with a vast amount of in-house collected data, accelerating the battery development process by 5-10x while enabling the widest range of potential chemistries. Currently shipping and in production, the company's batteries are up to 30% better than state-of-art technologies and are based on sustainable chemistries that contain low to no cobalt as well as zero nickel elements.
ClimateAI is an enterprise climate platform to help companies reduce, monitor, and adapt to physical climate risks. ClimateAi seeks to climate-proof the global economy while aiming for zero loss of lives, livelihoods, and nature. The company is a team of passionate entrepreneurs, scientists, and engineers who all believe that climate change is the most important problem of our generation.
Cohere is a platform that gives developers and businesses access to NLP, powered by the innovative generation of large language models. Cohere is used to build machines that understand the world and make it safely accessible to all. Cohere provides access to affordable, easy-to-deploy large language models. Its platform gives computers the ability to read and write.
Crossing Minds is the smartest platform powering perceptive recommendations that drive online discovery and engagement. Founded and led by world-renowned AI pioneers and powered by the latest advances in deep learning, Crossing Minds instantly delivers precise, session-based recommendations that don’t infringe on or jeopardize customer privacy. We help businesses engage their customers. We help people discover products they love. We help turn curiosity into loyalty.
DatologyAI is an AI-data curation startup that develops deep learning tools for automatic selection in data training. The company provides tools that help automate much of the creation of datasets. It identifies which information within a dataset is the most appropriate, based on what the AI model is designed to do. In addition, its tools can suggest ways to augment existing datasets with additional information, work out the best way to batch that information, or split it into more manageable chunks to streamline the model training process.
Genesis Therapeutics is a company that has its roots in academic research, which serves as the foundational element of its growing portfolio of AI technologies. The company employs a combination of innovative deep neural networks, biophysical simulation techniques, and highly scalable computing infrastructure. This amalgamation of technologies is geared towards achieving remarkable results in molecular generation and property prediction, particularly in the field of drug discovery and molecular design. Established in 2019 and headquartered in South San Francisco, California, Genesis Therapeutics focuses on leveraging innovative AI methodologies to enhance the efficiency and accuracy of molecular research. The company's approach holds promise in revolutionizing how molecules are generated and analyzed, potentially leading to advancements in drug development and related fields.
Graft is a Modern AI platform enabling data teams to build production-ready AI solutions in a few clicks. No machine learning skills, no need to hire a team, and no infrastructure to build or maintain. Take a data-centric approach that leverages foundation models to drive better business outcomes today.